Skip to content

Evaluation of the effect of larval source management and housing improvement when added to an existing malaria control strategy

Majete Malaria Project larval source management and housing improvement trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201604001501493
Enrollment
6480
Registered
2016-03-03
Start date
2016-05-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

Standard prevention with LLINs
LSM + HI (in addition to LLINs)
Larval Source Management (in addition to LLINs)
House Improvement (in addition to LLINs)

Sponsors

Wageningen University and Research Centre
Lead Sponsor
College of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All villages in the demarcated study site will initially be eligible for full participation in the trial. All households in trial villages will be eligible for entomological and epidemiological monitoring to assess trial outcomes. Within these households, children aged 6 to 59 months with informed consent from a guardian will be eligible for assessing parasitemia.

Exclusion criteria

Exclusion criteria: A buffer zone around each trial village, necessary for preventing contamination bias, will lead to the exclusion of some villages in the study site from the trial. This will be kept to a minimum, and done randomly by applying a spatial restriction to the village selection procedure.

Design outcomes

Primary

MeasureTime frame
Entomological inoculation rate;Prevalence of anaemia in children aged 6-59 months

Secondary

MeasureTime frame
Malaria vector community composition;Malaria vector human blood index;Peak malaria vector biting time;Larval mosquito density;Parasite prevalence in children aged 6-59 months;Incidence of clinical malaria in children aged 6-59 months

Countries

Malawi

Contacts

Public ContactWillem Takken

Professor / Wageningen University

willem.takken@wur.nl+31 317 48 46 52

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026